162 related articles for article (PubMed ID: 28549862)
1. Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis.
Choo MS; Jeong CW; Song C; Jeon HG; Seo SI; Hong SK; Byun SS; Chung JS; Hong SH; Hwang EC; Kim HH; Kwak C;
Clin Genitourin Cancer; 2017 Oct; 15(5):e819-e825. PubMed ID: 28549862
[TBL] [Abstract][Full Text] [Related]
2. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
Parihar A; Tickoo SK; Kumar S; Arora VK
Int J Surg Pathol; 2015 May; 23(3):234-7. PubMed ID: 25519951
[TBL] [Abstract][Full Text] [Related]
3. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Features of Translocation Renal Cell Carcinoma.
Ellati RT; Abukhiran I; Alqasem K; Jasser J; Khzouz J; Bisharat T; Al-Saidi I; Al-Daghmin A
Clin Genitourin Cancer; 2017 Feb; 15(1):112-116. PubMed ID: 27372562
[TBL] [Abstract][Full Text] [Related]
5. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
[TBL] [Abstract][Full Text] [Related]
7. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
8. Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?
Cheng X; He J; Gan W; Fan X; Yang J; Zhu B; Guo H
Int J Clin Exp Pathol; 2015; 8(5):5403-10. PubMed ID: 26191243
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of Xp11.2 translocation renal cell carcinoma.
Lim B; You D; Jeong IG; Kwon T; Hong S; Song C; Cho YM; Hong B; Hong JH; Ahn H; Kim CS
Korean J Urol; 2015 Mar; 56(3):212-7. PubMed ID: 25763125
[TBL] [Abstract][Full Text] [Related]
10. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.
Zhu QQ; Wang ZQ; Zhu WR; Chen WX; Wu JT
Acta Radiol; 2013 Apr; 54(3):355-62. PubMed ID: 23446748
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
12. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
13. Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study.
Zou H; Kang X; Pang LJ; Hu W; Zhao J; Qi Y; Hu J; Liu C; Li H; Liang W; Yuan X; Li F
Int J Clin Exp Pathol; 2014; 7(1):236-45. PubMed ID: 24427344
[TBL] [Abstract][Full Text] [Related]
14. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
16. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.
He J; Zhou K; Zhu B; Zhang G; Li X; Guo H; Gan W; Zhou Z; Liu T
Biomed Res Int; 2015; 2015():298679. PubMed ID: 26636097
[TBL] [Abstract][Full Text] [Related]
18. Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.
Liu N; Wang Z; Gan W; Xiong L; Miao B; Chen X; Guo H; Li D
PLoS One; 2016; 11(11):e0166897. PubMed ID: 27893792
[TBL] [Abstract][Full Text] [Related]
19. Xp11.2 translocation renal cell carcinomas in young adults.
Xu L; Yang R; Gan W; Chen X; Qiu X; Fu K; Huang J; Zhu G; Guo H
BMC Urol; 2015 Jul; 15():57. PubMed ID: 26126525
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness.
Chang K; Qu Y; Dai B; Zhao JY; Gan H; Shi G; Zhu Y; Shen Y; Zhu Y; Zhang H; Ye D
Sci Rep; 2017 May; 7(1):2074. PubMed ID: 28522811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
